• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

36.77 +0.29 (+0.79%)
Streaming Delayed Price Updated: 3:07 PM EDT, Apr 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,491,678
Open 36.09
Bid (Size) 36.76 (1,700)
Ask (Size) 36.77 (600)
Prev. Close 36.48
Today's Range 35.62 - 36.83
52wk Range 35.12 - 81.44
Shares Outstanding N/A
Dividend Yield 3.18%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Eli Lilly Secures Landmark FDA Approval for Oral Weight-Loss Pill, Sending Shares Soaring
Today 14:06 EDT
Shares of Eli Lilly and Company (NYSE: LLY) surged 3.8% on Wednesday following the milestone FDA approval of Foundayo (orforglipron), the first once-daily oral weight-loss pill that does not require... 
Via MarketMinute
Topics Economy
News headline image
The Evolution of The Cigna Group: A Deep Dive into a Health Services Powerhouse (2026)
Today 9:43 EDT
April 2, 2026 Introduction The Cigna Group (NYSE: CI) stands today at a pivotal crossroads, having undergone one of the most significant strategic transformations in the modern healthcare era. Long... 
Via Finterra
Topics Artificial Intelligence Economy Lawsuit

Performance

YTD
-29.8%
-29.8%
1 Month
-2.6%
-2.6%
3 Month
-27.7%
-27.7%
6 Month
-37.9%
-37.9%
1 Year
-46.0%
-46.0%

More News

Read More
News headline image
The Trillion-Dollar Treatment: A Deep Dive into Eli Lilly and Company (LLY)
Today 9:41 EDT
Via Finterra
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Why Eli Lilly Stock Trounced the Market Today ↗
April 01, 2026
Via The Motley Fool
News headline image
Eli Lilly’s $47.8 Billion Masterstroke: The Contessa Acquisition and the New Era of Pharmaceutical Dominance
April 01, 2026
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Could This New Approval Be a Turning Point For Novo Nordisk? ↗
April 01, 2026
Via The Motley Fool
News headline image
Is This Weight Loss Drug Stock a Buy After a New Approval? ↗
March 31, 2026
Via The Motley Fool
News headline image
The $1 Trillion Goliath: Why Eli Lilly’s $6.3B Centessa Bet Defines the Future of Neuroscience
March 31, 2026
Via Finterra
Topics Economy Intellectual Property
News headline image
1 Reason This Biotech Stock Could Triple Before Year-End ↗
March 29, 2026
Via The Motley Fool
News headline image
1 Reason Eli Lilly Stock Is Still a Buy ↗
March 28, 2026
Via The Motley Fool
Topics Artificial Intelligence
Novo Nordisk: A Strong Contender in the Pharmaceutical Arena ↗
March 27, 2026
Via The Motley Fool
News headline image
Eli Lilly Shares Slip Despite Positive Eczema Trial Results: Why the Market Reacted Coolly
March 27, 2026
Via MarketMinute
News headline image
Eli Lilly vs Novo Nordisk: Which Obesity Drug Stock Is the Better Buy? ↗
March 27, 2026
Via The Motley Fool
News headline image
Could Buying Eli Lilly Today Set You Up for Life? ↗
March 26, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
What's Happening With Novo Nordisk Stock Today? ↗
March 26, 2026
Via Benzinga
News headline image
Wave Life Sciences Shakes Biotech Sector with Breakthrough Obesity Data: A New Era for ‘Quality’ Weight Loss
March 26, 2026
Via MarketMinute
News headline image
Kodiak Sciences Surges 19% as Phase 3 GLOW2 Trial Delivers Vital Win for Diabetic Retinopathy Treatment
March 26, 2026
Via MarketMinute
News headline image
Surging Oil Prices Spark Market Jitters ↗
March 25, 2026
Via The Motley Fool
Topics Artificial Intelligence Economy Stocks
News headline image
The $6.7 Billion Pivot: A Deep Dive into Terns Pharmaceuticals (TERN) and the Merck Acquisition
March 25, 2026
Via Finterra
Topics Initial Public Offering Intellectual Property World Trade
News headline image
Think Novo Nordisk Can't Keep Up in the GLP-1 Market? Its Latest Drug Approval Could Be a Game Changer ↗
March 24, 2026
Via The Motley Fool
News headline image
Institutional Titans Bet Big on Amgen as Dividend Yield Hits 2.9% Benchmark
March 23, 2026
Via MarketMinute
Topics ETFs Earnings
News headline image
Got $1,500? Is It Better to Buy Bitcoin, or Viking Therapeutics? ↗
March 22, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Should You Buy Eli Lilly Stock Before April 10? ↗
March 22, 2026
Via The Motley Fool
News headline image
Is This Stock a Buy on the Dip? ↗
March 21, 2026
Via The Motley Fool
News headline image
This Hims & Hers Move Could Destroy Competitors ↗
March 21, 2026
Via The Motley Fool

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 36.77
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 04/02/26 03:07 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap